Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2024
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancerRomain-David Seban, Laurence Champion, Alexandre De Moura, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2023
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumabRomain-David Seban, Emilie Arnaud, Delphine Loirat, et al.
Advances in Radiation Oncology|March 18, 2024
Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life ExperienceThais Tison, Pierre Loap, Emilie Arnaud, et al.
Molecular Oncology|November 14, 2013
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencingLeticia De Mattos-Arruda, Francois-Clement Bidard, Helen H Won, et al.
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
Clinical Chemistry|January 12, 2017
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast CancerFrancesca Riva, Francois-Clement Bidard, Alexandre Houy, et al.
Plos One|July 5, 2013
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate CancerSjoerd T Ligthart, Frank A W Coumans, Francois-Clement Bidard, et al.
Journal of Clinical Medicine|August 12, 2023
PET/CT and SPECT/CT Imaging of HER2-Positive Breast CancerJeremy McGale, Sakshi Khurana, Alice Huang, et al.
Pageof 5